Nathan D. Trinklein

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN.

Welltok, Inc. is a consumer activation solutions company that improves people's total wellbeing. It offers proprietary data, advanced analytics, software-as-a-service software, and professional services to engage consumers in personalized and rewarding ways to drive action. The company was founded Jeff Cohen, Carlos C. Cardona, Scott Rotermund, Chris Rotermund, Christopher Coloian, Stanley J. Nowak III, Paulo Matos, Patrick D. Mize, and John DiBiasi in 2009 and is headquartered in Denver, CO.

Predilytics, Inc. provides advanced healthcare analytic solutions. The firm engages in the provision of advanced healthcare analytic solutions to health plans, providers, and other risk-bearing entities. It applies its patented analytic tools to transform structured and unstructured client data, along with external data sources, into actionable insights. The company was founded by Hariharan Sundram and Chris Johnson in 2011 and is headquartered in Burlington, MA.

Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA.

Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT.

The Henry J. Kaiser Family Foundation, do-business-as Kaiser Family Foundation (KFF), is a non-profit, private operating foundation headquartered in San Francisco, California. The firm was founded in 1948, but it was completely remade in 1991. The foundation focuses on national health issues and the US role in global health policy. KFF develops and runs their own policy analysis, journalism and communications programs, sometimes in partnership with major news organizations.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California.

Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.

Telegraph Hill Partners Management Co. LLC (Telegraph Hill Partners) is a venture capital firm founded in 2001 by Robert G. Shepler, Thomas A. Raffin and Deval A. Lashkari. The firm is headquartered in San Francisco, California.

Essential Access Health provides family healthcare services. Its services include clinic support initiatives, advanced clinical research, provider training, patient education, advocacy, and consumer awareness. The company was founded in 1968 and is headquartered in Los Angeles, CA.

The HudsonAlpha Institute for Biotechnology is a non-profit organization. It focuses on conducting genomics-based research to improve human health and well being; implementing genomic medicine, sparking economic development; and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a biotech literate public. The company was founded by James R. Hudson, Jr. and Lonnie S. McMillian in 2008 and is headquartered in Huntsville, AL.

Proxygen Co. is an American biotech company focused on the discovery and development of molecular glue degraders against targets of unmet medical need across various indications. Proxygen's headquarters and laboratory operations are based in an undisclosed location, and the private company employs talent both locally and remotely all over. The company maintains strategic partnerships with Merck & Co, Boehringer Ingelheim, and Merck KGaA to co-create synergies along the drug development pipeline.

Part of Johnson & Johnson, Johnson & Johnson Innovation LLC focuses on accelerating innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's healthcare businesses. The company is based in South San Francisco, CA. Johnson & Johnson Innovation provides scientists, entrepreneurs, and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device, and consumer companies of Johnson & Johnson. The company connects with innovators through its regional innovation centers, Johnson & Johnson Innovation - JLABS, JJDC, Inc., and its business development teams to create customized deals and novel collaborations that speed up the development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools, and resources needed to help life science startups thrive, all with no strings attached. Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices.

Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA.

Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA.

CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH.

Girl Effect is an international non-profit organization that builds media for girls. The non-profit company is based in London, UK. The British company helps girls navigate their options and prioritize through their local brands and network of offices, reaching girls online and offline via girl-centered media and technology. It was founded in 2004, and the CEO is Farah Ramzan Golant.

Part of Canaan Management, Inc., Canaan Partners XI LLC provides investment services. The company is based in Wilmington, DE.

PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA.

Serotiny, Inc. is an ecological adaptation exhibited by some seed plants. The company was founded in Justin Farlow and Colin Farlow and is headquartered in San Francisco, CA.

Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA.

Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021.

Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020.

Artera, Inc. is an American artificial intelligence company that provides cancer therapy services. The company was founded by Andre Esteva and he has been the CEO since incorporation.